For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Sutro Biopharma, Inc.

USPTO Granted Patents = 52

EPO Patents = 18

Trademarks = 9

Forward Citations = 186

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Christopher D Thanos (25 out of 57 patents)

Ryan Stafford (20 out of 23 patents)

Gang Yin (18 out of 19 patents)

4. Alice Yam (14 out of 15 patents)

5. Avinash Gill (11 out of 11 patents)

6. Kalyani Penta (10 out of 11 patents)

7. Xiaofan Li (9 out of 10 patents)

8. Ramesh Baliga (8 out of 26 patents)

9. Wenjin Yang (8 out of 36 patents)

10. Sunil Bajad (7 out of 7 patents)

11. Junhao Yang (6 out of 9 patents)

12. Leslie McEvoy (6 out of 8 patents)

13. Sonia Pollitt (6 out of 7 patents)

14. Chris Murray (6 out of 6 patents)

15. Alex Steiner (6 out of 6 patents)

Core Competencies:

Anti-Folate Receptor Antibody Conjugates

Oxidative Cytoplasm Strains

Engineered CH2 Domains

Full-Length Antibodies Production

Modified Fc Proteins

Anti-ROR1 Antibody Conjugates

Hemiasterlin Derivatives

Immunomodulator Antibody Drug Conjugates

Anti-CD74 Antibody Conjugates

Biologically Active Proteins Expression

Non-Natural Amino Acid Residues

Ribosomal Display Technology

52 patents: Sort by Forward Citations

1. 12427201 - Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates (2025-09-30),

2. 12410393 - strains having an oxidative cytoplasm (2025-09-09),

3. 12398197 - Antibodies with engineered CH2 domains, compositions thereof and methods of using the same (2025-08-26),

4. 12351850 - Methods of producing full-length antibodies using (2025-07-08),

5. 12269801 - Modified amino acids (2025-04-08),

6. 12252552 - Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use (2025-03-18),

7. 12226490 - Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class (2025-02-18),

8. 12144869 - Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates (2024-11-19),

9. 12098406 - Formulations for drying bacterial cell extracts (2024-09-24),

10. 12071477 - Anti-folate receptor alpha antibody conjugated with hemiasterlins (2024-08-27),

11. 11993658 - Anti-BCMA antibodies and treatment methods (2024-05-28),

12. 11958909 - Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2024-04-16),

13. 11866515 - Hemiasterlin derivatives for conjugation and therapy (2024-01-09),

14. 11744876 - Immunomodulator antibody drug conjugates and uses thereof (2023-09-05),

15. 11708413 - Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates (2023-07-25),

Sutro Biopharma, Inc. is a clinical-stage company specializing in the development of antibody-drug conjugates (ADCs) for targeted cancer therapies. Their platform integrates cell-free ribosome synthesis, rational protein design, and bioconjugation to create novel ADCs that enhance efficacy and reduce side effects. With a focus on difficult-to-treat solid tumors, Sutro Biopharma aims to revolutionize cancer treatment through innovative science and precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

52 Patents

#24 in South San Francisco, CA

#1,546 in California

#6,542 in US

#13,162 in the World

South San Francisco, CA, United States of America

Sutro Biopharma, Inc.

Forward Citations = 186

51 inventors:

Christopher D Thanos (25 out of 57 patents)

Ryan Stafford (20 out of 23 patents)

Gang Yin (18 out of 19 patents)

4. Alice Yam (14 out of 15 patents)

5. Avinash Gill (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…